1887

Journal of General Virology header logo

Volume 80, Issue 3

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection Free

Abstract

Cats were vaccinated with fixed autologous feline immunodeficiency virus (FIV)-infected cells in order to present viral proteins to the immune system of individual cats in an MHC-matched fashion. Upon vaccination, a humoral response against Gag was induced. Furthermore, virus-neutralizing antibodies were detected in a Crandell feline kidney cell-based neutralization assay, but not in a neutralization assay based on primary peripheral blood mononuclear cells. Despite the induction of these FIV-specific responses, vaccinated cats were not protected. Instead, accelerated virus replication was found, an observation similar to what previous experiments using other vaccine candidates have shown. Here, the results of the present study are discussed in the light of enhancement of lentivirus infections as a complicating factor in lentivirus vaccine development.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-3-761
1999-03-01
2024-05-10
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/3/0800761a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-3-761&mimeType=html&fmt=ahah

References

  1. Allan J. S., Strauss J., Buck D. W. 1990; Enhancement of SIV infection with soluble receptor molecules. Science 247:1084–1088
     [Google Scholar]
  2. Brichacek B., Swindells S., Janoff E. N., Pirruccello S., Stevenson M. 1996; Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. Journal of Infectious Diseases 174:1191–1199
     [Google Scholar]
  3. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. 1996; The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135–1148
     [Google Scholar]
  4. Flynn J. N., Beatty J. A., Cannon C. A., Stephens E. B., Hosie M. J., Neil J. C., Jarrett O. 1995; Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Research and Human Retroviruses 11:1107–1111
     [Google Scholar]
  5. Flynn J. N., Keating P., Hosie M. J., Mackett M., Stephens E. B., Beatty J. A., Neil J. C., Jarrett O. 1996; Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. Journal of Immunology 157:3658–3665
     [Google Scholar]
  6. Goletti D., Weissman D., Jackson R. W., Graham N. M., Vlahov D., Klein R. S., Munsiff S. S., Ortona L., Cauda R., Fauci A. S. 1996; Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. Journal of Immunology 157:1271–1278
     [Google Scholar]
  7. Ho D. D. 1992; HIV-1 viraemia and influenza. Lancet 339:1549
     [Google Scholar]
  8. Hosie M. J., Flynn J. N. 1996; Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. Journal of Virology 70:7561–7568
     [Google Scholar]
  9. Hosie M. J., Osborne R., Reid G., Neil J. C., Jarrett O. 1992; Enhancement after feline immunodeficiency virus vaccination. Veterinary Immunology and Immunopathology 35:191–197
     [Google Scholar]
  10. Hulskotte E. G. J., Dings M. E. M., Norley S. G., Osterhaus A. D. M. E. 1997; Chemical inactivation of recombinant vaccinia viruses and the effect on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins. Vaccine 15:1839–1845
     [Google Scholar]
  11. Kostrikis L. G., Cao Y., Ngai H., Moore J. P., Ho D. D. 1996; Quantitative analysis of serum neutralisation of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralisation serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. Journal of Virology 70:445–458
     [Google Scholar]
  12. Lombardi S., Garzelli C., Pistello M., Massi C., Matteucci D., Baldinotti F., Cammarota G., da Prato L., Bandecchi P., Tozzini F., Bendinelli M. 1994; A neutralising antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. Journal of Virology 68:8374–8379
     [Google Scholar]
  13. Montelaro R. C., Grund C., Raabe M., Woodson B., Cook R. F., Cook S., Issel C.J. 1996; Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines. AIDS Research and Human Retroviruses 12:413–415
     [Google Scholar]
  14. Ogg G. S., Jin X., Bonhoeffer S., Dunbar P. R., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S. L., Cerundolo V., Hurley A., Markowitz M., Ho D. D., Nixon D. F., McMichael A. J. 1997; Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103–2106
     [Google Scholar]
  15. Osterhaus A., de Vries P., Heeney J. 1992; AIDS vaccine developments. Nature 355:684–685
     [Google Scholar]
  16. Poignard P., Klasse P. J., Sattentau Q. J. 1996; Antibody neutralization of HIV-1. Immunology Today 17:239–246
     [Google Scholar]
  17. Richardson J., Moraillon A., Baud S., Cuisinier A. M., Sonigo P., Pancino G. 1997; Enhancement offeline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. Journal of Virology 71:9640–9649
     [Google Scholar]
  18. Rimmelzwaan G. F., Siebelink K. H. J., Huisman R. C., Moss B., Francis M. J., Osterhaus A. D. M. E. 1994; Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. Journal of General Virology 75:2097–2102
     [Google Scholar]
  19. Schutten M., Andeweg A. C., Bosch M. L., Osterhaus A. D. 1995; Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scandinavian Journal of Immunology 41:18–22
     [Google Scholar]
  20. Siebelink C. H., Windrich R. W., Chu I., Groen J., Weijer K., UytdeHaag F. G., Osterhaus A. D. 1990; An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunedeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum. Development in Biological Standardization 72:189–196
     [Google Scholar]
  21. Siebelink K. H., Chu I. H., Rimmelzwaan G. F., Weijer K., Osterhaus A. D., Bosch M. L. 1992; Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. Journal of Virology 66:1091–1097
     [Google Scholar]
  22. Siebelink K. H., Rimmelzwaan G. F., Bosch M. L., Meloen R. H., Osterhaus A. D. 1993; A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. Journal of Virology 67:2202–2208
     [Google Scholar]
  23. Siebelink K. H., Tijhaar E., Huisman R. C., Huisman W., de Ronde A., Darby I. H., Francis M. J., Rimmelzwaan G. F., Osterhaus A. D. 1995; Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. Journal of Virology 69:3704–3711
     [Google Scholar]
  24. Sozzani S., Ghezzi S., Iannolo G., Luini W., Borsatti A., Polentarutti N., Sica A., Locati M., Mackay C., Wells T. N., Biswas P., Vicenzi E., Poli G., Mantovani A. 1998; Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. Journal ofExperimental Medicine 187:439–444
     [Google Scholar]
  25. Staprans S. I., Hamilton B. L., Follansbee S. E., Elbeik T., Barbosa P., Grant R. M., Feinberg M. B. 1995; Activation ofvirus replication after vaccination of HIV-1-infected individuals. Journal of Experimental Medicine 182:1727–1737
     [Google Scholar]
  26. Stott E. J. 1991; Anti-cell antibody in macaques. Nature 353:393
     [Google Scholar]
  27. van Baalen C. A., Pontesilli O., Huisman R. C., Geretti A. M., Klein M. R., de Wolf F., Miedema F., Gruters R. A., Osterhaus A. D. M. E. 1997; Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. Journal of General Virology 78:1913–1918
     [Google Scholar]
  28. Wang S. Z., Rushlow K. E., Issel C. J., Cook R. F., Cook S. J., Raabe M. L., Chong Y. H., Costa L., Montelaro R. C. 1994; Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247–251
     [Google Scholar]
  29. Willett B. J., Flynn J. N., Hosie M. J. 1997; FIV infection of the domestic cat: an animal model forAIDS. Immunology Today 18:182–189
     [Google Scholar]
  30. Yamamoto J. K., Okuda T., Ackley C. D., Louie H., Pembroke E., Zochlinski H., Munn R. J., Gardner M. B. 1991; Experimental vaccine protection against feline immunodeficiency virus. AIDS Research and Human Retroviruses 7911–922
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-3-761
Loading
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection
J. Gen. Virol. 80, 761 (1999); https://doi.org/10.1099/0022-1317-80-3-761
/content/journal/jgv/10.1099/0022-1317-80-3-761
/content/journal/jgv/10.1099/0022-1317-80-3-761
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error